NanoViricides
NNVC
48 hedge funds and large institutions have $1.73M invested in NanoViricides in 2026 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 8 closing their positions.
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
51% less capital invested
Capital invested by funds: $3.51M → $1.73M (-$1.78M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 | +$189K | |
| 2 | +$60.8K | |
| 3 | +$53.4K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$49.4K |
| 5 |
MFS
Miller Financial Services
Marshall,
Michigan
|
+$34.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 | -$1.55M | |
| 2 | -$105K | |
| 3 | -$83.6K | |
| 4 |
Renaissance Technologies
New York
|
-$40.3K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$19.4K |
NNVC Hedge Fund Activity: Q1 2026 in Review
48 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q1 2026, worth a combined $1.73M — down 51% from $3.51M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new NNVC positions and 8 closed out — a net gain of 6 holders — while 9 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, adding an estimated $189K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.55M sold.
- 48 institutional investors held NanoViricides (NNVC) as of Q1 2026, up from 43 in Q4 2025.
- Funds reported $1.73M of NanoViricides stock for Q1 2026, down 51% quarter-over-quarter.
- 14 funds opened new NanoViricides positions in Q1 2026 and 8 closed out, a net change of +6 holders.
- The largest NanoViricides buyer in Q1 2026 was UBS Group, an estimated $189K added.
- The largest NanoViricides seller in Q1 2026 was Armistice Capital, an estimated $1.55M sold.
Based on aggregated 13F filings for Q1 2026.